Tarlige Most Pitched Drug in April: Impact Track Survey

July 19, 2019
Daiichi Sankyo’s peripheral neuropathic pain treatment Tarlige (mirogabalin) was the most promoted drug in the month of April, with its sales reps stepping up their calls as the product hit the market in middle of the month, an industry survey...read more